Skip to main content

Enanta Pharmaceuticals Inc

ENTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001177648

No open-market purchases or sales by Enanta Pharmaceuticals Inc insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $397.2M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Enanta Pharmaceuticals Inc changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of ENTA: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders112108−4
Shares21.2M19.9M−1.32M (−6.2%)
Value$220.0M$114.5M−$105.5M (−48.0%)

New holders (23)

Institutions that held Enanta Pharmaceuticals Inc at the end of Q4 2024 but not at the end of Q3 2024.

Sold out (27)

Institutions that held Enanta Pharmaceuticals Inc at the end of Q3 2024 and filed for Q4 2024 without it.